DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. 1997

D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
Department of Urology, University of Athens, Greece.

The identification of new prognostic parameters in Superficial Transitional Cell Carcinoma of the Bladder (STCCB) is important since conventional methods are often insufficient for prognostic purposes. We studied the proliferation activity and the DNA ploidy status of 60 pTa and pT1 Superficial Transitional Cell Carcinoma of the Bladder in relation to grade and recurrence rate. The proliferative activity was investigated by measuring the PCNA expression in paraffin embedded tissue sections. The DNA content was studied in Feulgen stained imprints by image analysis technique using a SAMBA 2005 analyser. According to our measurements a statistically significant difference was found in PCNA expression among tumors grade I, grade II, grade III (F = 5.43, p < 0.001), between tumors of the same grade with, and without recurrence (p < 0.001); and between recurrent and non-recurrent tumors (T58 = -6.03, p < 0.001). A statistically significant difference was also observed concerning the DNA-index among grade I, grade II and grade III (F = 4.81, p < 0.01), and between recurrent and non-recurrent tumors concerning the DNA DNA ploidy status (DNA-euploid vs. DNA-aneuploid tumors) (X2 = 24.96, p < 0.001). The recurrence status is also strongly influenced by the proliferation rate and the DNA ploidy status of tumors (X23 = 41.19, p < 0.001). No cases recurrence were found in the group of DNA-euploid tumors with PCNA. expression lower than 30%, in contrast a very high percentage of recurrence in patients with DNA-aneuploid tumors with PCNA expression higher than 30%. Although a small proportion of cases could not be included in me previous categories, STCCB may be classified in to main groups concerning the risk of recurrence. In keeping with this view of proliferation rate and DNA ploidy status could provide useful information, on the potential malignancy of Superficial Transitional Cell Carcinoma of the Bladder. However further studies are required to establish the clinical utility of these parameters.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
May 1994, British journal of urology,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
May 1982, Harefuah,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
November 1993, Seminars in urology,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
December 1983, Harefuah,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
August 1993, Seminars in urology,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
January 1992, Zhonghua zhong liu za zhi [Chinese journal of oncology],
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
March 2006, Urology,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
January 1995, Harefuah,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
July 2004, BJU international,
D Pantazopoulos, and A Ioakim-Liossi, and P Karakitsos, and K Aroni, and S Kakoliris, and P Kanavaros, and K A Kyrkou
May 1993, The Journal of urology,
Copied contents to your clipboard!